Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study
Yining Huang(Nanjing University of Chinese Medicine), Chen Yao(Peking University), Jinsheng Zeng(Sun Yat-sen University), Ka Sing Wong(Prince of Wales Hospital), Meiping Ding(Second Affiliated Hospital of Zhejiang University), Weiwei Zhang(Sun Yat-sen University), Zhengyi Li(First Affiliated Hospital of Xi'an Jiaotong University), Yan Cheng(Central South University), Jiang Wu(Jilin University), Yansheng Li(Renji Hospital), Zhen Hong(Fudan University), Xuguang Gao(Peking University), Chuanzhen Lü(Fudan University), Dongsheng Fan(King University), Jiangxi Xiao(Peking University), En Xu(Jiangsu University)
Cited by 262
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Estimated Burden of Stroke in China in 2020
|JAMA Network Open|2023|595
China stroke surveillance report 2021
|Military Medical Research|2023|554